By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on KO, citing high valuation, slowing beverage demand, and structural risks like GLP-1 drugs and regulatory pressures that could cap growth and undercut the 'lifetime income' thesis.
Risk: GLP-1 drugs leading to a structural shift in caloric intake and making KO's core portfolio obsolete
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Coca-Cola (NYSE: KO), the world's largest beverage company, is a reliable blue chip stock. Including reinvested dividends, it delivered a total return of 659% over the past 30 years. Let's see why it's still a great stock to buy today to generate passive income for life.
Over the past few decades, Coca-Cola has expanded its beverage portfolio with more brands of bottled water, fruit juices, teas, sports drinks, energy drinks, dairy products, coffee, and even alcoholic beverages. It also refreshed its flagship sodas with smaller serving sizes, new flavors, and healthier versions. That ongoing expansion and evolution enabled the company to continue growing, even as soda consumption rates fell worldwide.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Coca-Cola only produces the concentrates and syrups for those beverages, then sells them to independent bottlers, restaurants, and other businesses that produce the finished drinks. That asset-light business model enables it to maintain high operating margins while generating stable cash flow and earnings, even amid economic downturns or choppy macro headwinds. It also doesn't own a struggling packaged foods segment like PepsiCo (NASDAQ: PEP).
That's also why Coca-Cola raised its dividend annually for 64 consecutive years. That makes it an elite Dividend King, having hiked its payout for at least 50 consecutive years. It currently pays a forward dividend yield of 2.6%. That yield might not seem impressive when the 10-Year Treasury still pays 4.5%, but it will attract more attention as interest rates decline.
From 2025 to 2028, analysts expect Coca-Cola's EPS to grow at 6.5% CAGR. That growth will be driven by its AI-powered inventory optimization strategies, the ongoing consolidation of its bottling network, as well as its stronger sales of dairy, energy, and sugar-free drinks. Its bottling partners will also continue to sell a higher mix of smaller, higher-margin cans.
At $83, Coca-Cola's stock still looks reasonably valued at 25 times its trailing earnings. By comparison, the S&P 500 looks historically expensive at 32 times earnings. Rising inflation, the Middle East conflict, and other macro headwinds could deflate those valuations in the second half of 2026.
If that market pullback happens, more investors will rotate toward safe-haven stocks like Coca-Cola. Therefore, it seems to be a great time to buy more shares of Coca-Cola -- and commit to holding them for decades -- to earn a lifetime of reliable dividends.
Before you buy stock in Coca-Cola, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Coca-Cola wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $433,268! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,259,391!
Now, it’s worth noting Stock Advisor’s total average return is 935% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 13, 2026. *
Leo Sun has positions in Coca-Cola. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"KO's 2.6% yield and 6.5% growth at 25x earnings offer limited appeal versus bonds or faster compounders when interest rates remain elevated."
The article pushes KO as a Dividend King for lifetime income, citing 64 years of hikes, 2.6% yield, 25x trailing P/E vs. S&P 500's 32x, and 6.5% EPS CAGR through 2028 from AI, bottling tweaks, and mix shift to energy/dairy. Yet it glosses over the 4.5% 10-year Treasury yield creating immediate opportunity cost, the asset-light model's vulnerability to bottler disputes or input-cost spikes, and slow volume growth amid health-driven soda declines. No specific June catalyst justifies timing, and the 659% 30-year return includes a very different rate environment.
Even at 6.5% growth, KO's defensive cash flows and pricing power could still deliver superior risk-adjusted returns if macro shocks trigger a broad de-rating of the S&P 500's 32x multiple.
"The 'buy and hold for life' case for Coca-Cola rests on optimistic growth and AI-driven efficiency that may not materialize, while current valuation and structural risks imply limited upside."
KO is a classic defensive name, but the article leans on optimistic growth and AI-magic that may not materialize. The stock trades at 25x trailing earnings with only a 2.6% forward yield, while core risks include slowing beverage demand in developed markets, regulatory pressure on sugar and packaging, and margin headwinds from currency and bottler pass-throughs. The claim of 6.5% EPS growth 2025–2028 hinges on bottler consolidation and new product mix, which are not guaranteed in a mature category. In a rising-rate world, the upside from a 'lifetime income' thesis looks capped.
KO's dividend streak is durable but not a guarantee of future growth; the premise that future cash flows will support continued 2.6% yield and 6.5% EPS growth relies on assumptions that could easily fail, especially if consumer preferences shift, regulatory costs rise, or bottler margins compress.
"At 25x trailing earnings, Coca-Cola is currently priced for perfection, leaving little margin of safety for investors given the structural threats from GLP-1 adoption and stagnant volume growth."
The article's 'buy and hold forever' thesis ignores the reality of KO's valuation compression risk. Trading at 25x trailing earnings for a company with a 6.5% EPS CAGR is expensive, especially when the 10-year Treasury yield provides a superior risk-free alternative at 4.5%. While the 'asset-light' model is a defensive moat, the company faces structural headwinds from GLP-1 weight-loss drugs, which directly threaten the long-term consumption volume of high-sugar beverages. Investors are paying a premium for a 'Dividend King' status that may see its growth ceiling lowered by changing consumer health preferences and saturation in developed markets. This is a bond proxy masquerading as a growth play.
If Coca-Cola successfully pivots its portfolio toward non-sugar, functional beverages and leverages AI-driven pricing power to offset volume declines, the 25x multiple could be justified as a defensive premium in an uncertain macro environment.
"KO's valuation discount to the S&P 500 is illusory once you normalize for its sub-market growth rate, and the dividend yield only works as a return driver if rates decline materially from here."
The article conflates backward-looking returns (659% over 30 years) with forward-looking opportunity, a common trap. KO trades at 25x trailing P/E versus S&P 500 at 32x — but that 'discount' evaporates when you account for 6.5% EPS CAGR (2025-2028) versus broad market growth. The 2.6% yield only becomes attractive if rates fall sharply; if they don't, KO underperforms risk-free Treasuries. The asset-light model is real, but it's priced in. The article's June timing and 'never sell' framing are marketing, not analysis. Biggest omission: KO's exposure to volume headwinds in developed markets and currency headwinds in emerging markets — both glossed over.
If rates stay elevated or rise further, KO's 2.6% yield becomes a value trap, and the 'safe haven' rotation narrative fails. Meanwhile, 6.5% EPS growth barely beats inflation, leaving zero real return cushion if multiples compress.
"GLP-1 and EM currency risks compound into a volume cliff that invalidates the 6.5% CAGR at current valuation."
Gemini's GLP-1 volume threat connects directly to Claude's emerging-market currency exposure: both could accelerate if consumers trade down to cheaper local alternatives amid high rates. A 5% sustained volume drop in developed markets would require 300-400bp extra pricing just to hold the 6.5% EPS path, risking share loss that neither the asset-light model nor AI tweaks can fully offset at 25x.
"KO's 6.5% EPS path relies on aggressive price/mix gains to offset volume and currency headwinds, which is likely optimistic in a mature market and could lead to multiple compression even if the dividend remains."
Responding to Grok: The 5% sustained volume drop and 300–400bp pricing lift assume not only price elasticity but durable demand shifts and successful mix pivots. In a mature US/global beverage market, price resilience is limited and private-labels stiffen competition. Over 25x trailing earnings, investors are pricing in a best-case re-rating; any miss on volume or margin compression from currency/bottlers could trigger multiple downside, even if the dividend stays intact.
"GLP-1 adoption poses a permanent, structural threat to KO's core volume that pricing power cannot offset."
Gemini’s GLP-1 point is the true elephant in the room. While everyone focuses on price elasticity, the real risk is a structural shift in caloric intake that makes KO’s core portfolio obsolete. If GLP-1 adoption hits 10-15% of the US population, the 'pricing power' narrative collapses because demand becomes inelastic for the wrong reasons. We aren't just looking at volume declines; we are looking at a permanent impairment of the brand's addressable market.
"GLP-1 doesn't kill KO's addressable market; it forces a painful margin-dilutive product mix shift that 25x multiples don't adequately price."
Gemini's GLP-1 thesis assumes adoption scales to 10-15% and directly cannibilizes KO's core. But that's speculative. GLP-1 users still consume beverages—just lower-calorie ones. KO owns Dasani, Sprite Zero, Minute Maid. The real risk isn't obsolescence; it's margin compression if KO must trade mix toward lower-margin diet/zero products faster than pricing can offset. That's a 200-300bp headwind, not a death sentence—but it's the actual mechanism nobody quantified.
The panel consensus is bearish on KO, citing high valuation, slowing beverage demand, and structural risks like GLP-1 drugs and regulatory pressures that could cap growth and undercut the 'lifetime income' thesis.
None identified
GLP-1 drugs leading to a structural shift in caloric intake and making KO's core portfolio obsolete